Joint working is becoming an increasingly important part of the healthcare system and involves NHS and pharmaceutical professionals coming together to develop projects that improve patient health. The new ABPI guide, which is supported by the Department of Health and NHS Confederation, provides a quick reference for those who are considering launching new schemes and it is hoped it will encourage more joint working projects in the future.
The guide is designed for use by both NHS and industry partners, and has been developed around a simple seven step flow chart from the initial idea generation, through development, to a final agreement.
Commenting, Stephen Whitehead, Chief Executive of the ABPI, said:
“Initiating a joint working project can be challenging, despite the clear benefits to patients of combining pharmaceutical industry and NHS expertise. I believe this guide can help overcome those challenges and I hope this will be widely shared by my own colleagues and those in the NHS. Ultimately I want this to spark new ideas that will help improve health outcomes and transform the lives of patients.”
Commenting, Mike Farrar, Chief Executive of the NHS Confederation, said:
“Supporting and developing new ideas has never really been a problem in that there have always been plenty of innovative ideas out there. The real problem has always been that the NHS has found it difficult to spread these ideas throughout the system. This guide will be a useful tool in helping build the foundations between the NHS and industry partners so, together, we can help create innovative new services to benefit patients.”
Joint working has already benefited thousands of patients across the UK, with projects contributing towards the reduction of COPD admissions, improving healthcare for diabetes patients and reducing heart disease.
ABPI Press Office
Tel: +44 (0) 20 7747 1410 or +44 (0) 20 7747 1441
Mobile: +44 (0) 7808 641810 or +44 (0) 7850 312064
Notes to Editor
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all branded medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.
NHS Confederation represent all organisations that commission and provide NHS services.
Our members include acute trusts, ambulance trusts, clinical commissioning groups, community health service providers, foundation trusts, mental health providers, primary care trusts and a growing number of independent and voluntary sector healthcare organisations that deliver services within the NHS.
We represent the NHS as a whole and also have a number of networks and forums to support our members in areas of specific concern to their part of the healthcare system.